BDBM172454 US20240307363, Compound 5::US9090625, 6::US9260450, 6::US9938289, 6

SMILES Cc1nn(c(c1C)-c1cc2cnccc2s1)-c1cccc(C)n1

InChI Key InChIKey=TVXWXMHIKISOHR-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 172454   

TargetTGF-beta receptor type-1(Human)
Thesan Pharmaceuticals

US Patent
LigandPNGBDBM172454(US9090625, 6 | US9260450, 6 | US9938289, 6 | US202...)
Affinity DataIC50: 35.2nMAssay Description:Pharmacol 2002, 62 58-62) The compounds named in the specified Examples were tested as follows for inhibition of ALK-5 autophosphorylation activity a...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/21/2016
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Thesan Pharmaceuticals

US Patent
LigandPNGBDBM172454(US9090625, 6 | US9260450, 6 | US9938289, 6 | US202...)
Affinity DataIC50: 35.2nMpH: 7.6 T: 2°CAssay Description:In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 ul Assay Buffer (50 mM HEPES, pH 7.6, with 10 mM NaCl, 10 mM MgCl2, and 1 mM DTT ) is ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Thesan Pharmaceuticals

US Patent
LigandPNGBDBM172454(US9090625, 6 | US9260450, 6 | US9938289, 6 | US202...)
Affinity DataIC50: 244nMAssay Description:ALK-5 gene reporter assay methods have been described in the art (see e.g., Maliekal et al. (2004) J Biol Chem 279(35):36287-36292). The compounds na...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/9/2017
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Thesan Pharmaceuticals

US Patent
LigandPNGBDBM172454(US9090625, 6 | US9260450, 6 | US9938289, 6 | US202...)
Affinity DataIC50: 35.2nMAssay Description:ALK-5 kinase assay methods have been described in the art (see e.g., Laping et al. (2002) Mol. Pharmacol. 2002; 62: 58-62). The compounds named in th...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/2/2020
Entry Details
Go to US Patent

TargetTGF-beta receptor type-1(Human)
Thesan Pharmaceuticals

US Patent
LigandPNGBDBM172454(US9090625, 6 | US9260450, 6 | US9938289, 6 | US202...)
Affinity DataIC50: 35.2nMAssay Description:In a 96 well filter-bottom plate (Millipore, #MSDV N6B 50), 58 μL Assay Buffer is added to reach well. Add 10 μL of Cold ATP mix in Assay B...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/16/2025
Entry Details
Go to US Patent